Knapp Thomas J c/o Sucampo Pharmaceuticals, Inc.
SEC-identified person · CIK 1311726 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ascentage Pharma Group International AAPG | SVP/General Counsel | filed 2026–2026 |
| Osiris Therapeutics, INC. OSIR | Director | filed 2018–2018 |
| Sellas Life Sciences Group, Inc. gale | General Counsel | filed 2015–2017 |
| Sucampo Pharmaceuticals, Inc. SCMP | Director · SVP, Gen Counsel & Corp. Secy | filed 2010–2015 |
| Northwestern Corp NWEC | VP- General Counsel | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.